Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-05-2023 | Lung Cancer | Case report

Antineoplastics

Posterior reversible encephalopathy syndrome, grade 3 oral ulcer and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Zou X, et al. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review. Frontiers in Pharmacology 14: 1-8, et al. Feb 2023. Available from: URL: http://www.frontiersin.org/Pharmacology Zou X, et al. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review. Frontiers in Pharmacology 14: 1-8, et al. Feb 2023. Available from: URL: http://​www.​frontiersin.​org/​Pharmacology
Metadata
Title
Antineoplastics
Posterior reversible encephalopathy syndrome, grade 3 oral ulcer and lack of efficacy: case report
Publication date
01-05-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-39174-3

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Colchicine

Case report

Icotinib misuse

Case report

Brodalumab